Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation

T. F. Müller, F. Trösch, H. Ebel, Rainer W G Gruessner, H. Feiber, B. Göke, B. Greger, H. Lange

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A reliable, noninvasive indicator of pancreatic allograft rejection is urgently needed. In this study, serum (S), plasma (P), and urine (U) levels of pancreas-specific protein (P-PASP, U-PASP), neopterin (S-NEOP, U-NEOP), amylase (U-AMYL), and amyloid A (SAA) were measured daily in ten type I diabetic patients following simultaneous pancreas and kidney transplantation (SPK). Rejection episodes occurred in three isolated pancreas, nine isolated kidney, and five simultaneous pancreas and kidney transplants. In the case of the eight pancreas rejections, SAA was the rejection marker with the highest diagnostic accuracy (94%). Using P-PASP and U-PASP, an accuracy of 81% and 79%, respectively, was achieved. During viral infections, U-NEOP levels increased to a maximum level of 1904 μmol/mol creatinine, whereas during bacterial infections, SAA levels increased to a maximum value of 43 mg/dl. SAA, measured for the first time in SPK, appears to be a valuable rejection parameter. In combination with U-NEOP and U-AMYL, a differential diagnosis between rejection, bacterial infection, and viral infection was possible. Neither U-PASP nor P-PASP monitoring led to a significant improvement in the results.

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalTransplant International
Volume10
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Neopterin
Serum Amyloid A Protein
Pancreas Transplantation
Kidney Transplantation
Pancreas
Proteins
Virus Diseases
Amylases
Bacterial Infections
Kidney
Protein S
Amyloid
Allografts
Creatinine
Differential Diagnosis
Urine

Keywords

  • Neopterin, pancreas transplantation
  • Pancreas transplantation, rejection parameters
  • Pancreas-specific protein, pancreas transplantation
  • Rejection, pancreas transplantation
  • Serum amyloid A, pancreas transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation. / Müller, T. F.; Trösch, F.; Ebel, H.; Gruessner, Rainer W G; Feiber, H.; Göke, B.; Greger, B.; Lange, H.

In: Transplant International, Vol. 10, No. 3, 1997, p. 185-191.

Research output: Contribution to journalArticle

@article{812a6843c29148719d8f80e907c2c666,
title = "Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation",
abstract = "A reliable, noninvasive indicator of pancreatic allograft rejection is urgently needed. In this study, serum (S), plasma (P), and urine (U) levels of pancreas-specific protein (P-PASP, U-PASP), neopterin (S-NEOP, U-NEOP), amylase (U-AMYL), and amyloid A (SAA) were measured daily in ten type I diabetic patients following simultaneous pancreas and kidney transplantation (SPK). Rejection episodes occurred in three isolated pancreas, nine isolated kidney, and five simultaneous pancreas and kidney transplants. In the case of the eight pancreas rejections, SAA was the rejection marker with the highest diagnostic accuracy (94{\%}). Using P-PASP and U-PASP, an accuracy of 81{\%} and 79{\%}, respectively, was achieved. During viral infections, U-NEOP levels increased to a maximum level of 1904 μmol/mol creatinine, whereas during bacterial infections, SAA levels increased to a maximum value of 43 mg/dl. SAA, measured for the first time in SPK, appears to be a valuable rejection parameter. In combination with U-NEOP and U-AMYL, a differential diagnosis between rejection, bacterial infection, and viral infection was possible. Neither U-PASP nor P-PASP monitoring led to a significant improvement in the results.",
keywords = "Neopterin, pancreas transplantation, Pancreas transplantation, rejection parameters, Pancreas-specific protein, pancreas transplantation, Rejection, pancreas transplantation, Serum amyloid A, pancreas transplantation",
author = "M{\"u}ller, {T. F.} and F. Tr{\"o}sch and H. Ebel and Gruessner, {Rainer W G} and H. Feiber and B. G{\"o}ke and B. Greger and H. Lange",
year = "1997",
doi = "10.1007/s001470050039",
language = "English (US)",
volume = "10",
pages = "185--191",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation

AU - Müller, T. F.

AU - Trösch, F.

AU - Ebel, H.

AU - Gruessner, Rainer W G

AU - Feiber, H.

AU - Göke, B.

AU - Greger, B.

AU - Lange, H.

PY - 1997

Y1 - 1997

N2 - A reliable, noninvasive indicator of pancreatic allograft rejection is urgently needed. In this study, serum (S), plasma (P), and urine (U) levels of pancreas-specific protein (P-PASP, U-PASP), neopterin (S-NEOP, U-NEOP), amylase (U-AMYL), and amyloid A (SAA) were measured daily in ten type I diabetic patients following simultaneous pancreas and kidney transplantation (SPK). Rejection episodes occurred in three isolated pancreas, nine isolated kidney, and five simultaneous pancreas and kidney transplants. In the case of the eight pancreas rejections, SAA was the rejection marker with the highest diagnostic accuracy (94%). Using P-PASP and U-PASP, an accuracy of 81% and 79%, respectively, was achieved. During viral infections, U-NEOP levels increased to a maximum level of 1904 μmol/mol creatinine, whereas during bacterial infections, SAA levels increased to a maximum value of 43 mg/dl. SAA, measured for the first time in SPK, appears to be a valuable rejection parameter. In combination with U-NEOP and U-AMYL, a differential diagnosis between rejection, bacterial infection, and viral infection was possible. Neither U-PASP nor P-PASP monitoring led to a significant improvement in the results.

AB - A reliable, noninvasive indicator of pancreatic allograft rejection is urgently needed. In this study, serum (S), plasma (P), and urine (U) levels of pancreas-specific protein (P-PASP, U-PASP), neopterin (S-NEOP, U-NEOP), amylase (U-AMYL), and amyloid A (SAA) were measured daily in ten type I diabetic patients following simultaneous pancreas and kidney transplantation (SPK). Rejection episodes occurred in three isolated pancreas, nine isolated kidney, and five simultaneous pancreas and kidney transplants. In the case of the eight pancreas rejections, SAA was the rejection marker with the highest diagnostic accuracy (94%). Using P-PASP and U-PASP, an accuracy of 81% and 79%, respectively, was achieved. During viral infections, U-NEOP levels increased to a maximum level of 1904 μmol/mol creatinine, whereas during bacterial infections, SAA levels increased to a maximum value of 43 mg/dl. SAA, measured for the first time in SPK, appears to be a valuable rejection parameter. In combination with U-NEOP and U-AMYL, a differential diagnosis between rejection, bacterial infection, and viral infection was possible. Neither U-PASP nor P-PASP monitoring led to a significant improvement in the results.

KW - Neopterin, pancreas transplantation

KW - Pancreas transplantation, rejection parameters

KW - Pancreas-specific protein, pancreas transplantation

KW - Rejection, pancreas transplantation

KW - Serum amyloid A, pancreas transplantation

UR - http://www.scopus.com/inward/record.url?scp=0031002494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031002494&partnerID=8YFLogxK

U2 - 10.1007/s001470050039

DO - 10.1007/s001470050039

M3 - Article

C2 - 9163857

AN - SCOPUS:0031002494

VL - 10

SP - 185

EP - 191

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 3

ER -